Updated
The Latest: German firm says vaccine good for younger people
TUBINGEN, Germany — German vaccine maker CureVac says younger people could benefit from its coronavirus shot, following disappointing results two weeks ago in a broader age group.
The company said Wednesday that its vaccine is 53% effective against COVID-19 of any severity in 18- to 60-year-olds. Overall, though, CurveVac says the shot is 48% effective, based on 83 cases in the vaccine group and 145 in the placebo group.
The World Health Organization has said vaccines with an efficacy above 50% are worth using, though many of those already approved have a far higher rate.